F sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant activation of PI3K/Akt
F sorafenib contained aberrant activation of PI3K/Akt pathway, stemnessF sorafenib contained aberrant activation of PI3K/Akt pathway, stemness plus the epithelialmesenchymal transition.16,50 It is practical for clinical therapy to know the…